The Future of Revascularization Using a Bioprotec Graft
REVATEC
The Future of the Revascularization Using a Bioprotec Graft
1 other identifier
observational
46
1 country
1
Brief Summary
The main purpose of this study is the rate assessment of rescued limbs, one year after a BIOPROTEC vascular graft.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Sep 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 10, 2019
CompletedFirst Posted
Study publicly available on registry
July 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 7, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 7, 2022
CompletedSeptember 19, 2024
September 1, 2023
3.1 years
July 10, 2019
September 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The Limb rescue rate one year after a BIOPROTEC graft
Usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular doctor in 1 month, 6 months, 12 months, 18 months and 2 years
Two years
Secondary Outcomes (3)
The revascularization permeability rate
Two years
The amputation rate
Two years
Infection resistance rate
Two years
Interventions
It is about a routine care study not changing the usual follow-up of patients: postoperative visits after a Doppler ultrasonography made by a vascular Doctor in 1 month, 6 months, 12 months, 18 months and 2 years.
Eligibility Criteria
Grafted patient with a vascular BIOPROTEC graft in case of a Peripheral artery disease.
You may qualify if:
- ≥ Eighteen years old.
- Critical ischemia (Phase 4-6 of Rutherford): no saphenous equipment for the vascular reconstruction; at least one leg axis permeable.
You may not qualify if:
- Pregnant woman.
- Patient with an acute ischemia.
- Patient with an exceeded ischemia.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hôpital NOVOlead
Study Sites (1)
Cntre Hospitalier René Dubos
Cergy-Pontoise, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jean-Michel DAVAINE, Dr
Pitié Salpêtrière Vascular Surgery Service
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 10, 2019
First Posted
July 15, 2019
Study Start
September 1, 2018
Primary Completion
October 7, 2021
Study Completion
October 7, 2022
Last Updated
September 19, 2024
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share